The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia

ICON Clinical Research Limited, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Medical Department, Division of Psychosomatic MedicineMunich

O’Hara, Jamie

HCD Economics, University of ChesterUK

O’Mahony, Brian

Irish Haemophilia Society, Trinity CollegeDublin

Pollard, Debra

Royal Free Hospital, Trustee of Haemnet, MASAG, European Haemophilia ConsortiumLondon

Skinner, Mark

Institute for Policy Advancement Ltd, McMaster UniversityWashington

Quinn, Jennifer

BioMarin UK LtdLondon, UK

Lingua:: Inglese

Frequenza di pubblicazione:: 1 volte all'anno
Argomenti della rivista:: Medicina, Scienze medicali di base, Scienze medicali di base, altro, Medicina clinica, Medicina clinica, altro, Farmacia, Farmacologia

Feed RSS della rivista

The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia

Monika Bullinger

Diandra Latibeaudiere Gardner

Hannah B Lewis

Wolfgang Miesbach

Sandra Nolte

Jamie O’Hara

Brian O’Mahony

Debra Pollard

Mark Skinner

Jennifer Quinn

Categoria dell'articolo: Clinical Research

Pubblicato online: 30 mag 2021

Pagine: 56 - 68

DOI: https://doi.org/10.17225/jhp00176

Parole chiaveHaemophilia, gene therapy, patient-reported outcomes, health-related quality of life

© 2021 Monika Bullinger et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Parole chiave
Haemophilia, gene therapy, patient-reported outcomes, health-related quality of life